<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02160119</url>
  </required_header>
  <id_info>
    <org_study_id>C13-26</org_study_id>
    <secondary_id>2013-A01315-40</secondary_id>
    <nct_id>NCT02160119</nct_id>
  </id_info>
  <brief_title>Emotional and Change-related Attention in Autism</brief_title>
  <acronym>AUTATTEN</acronym>
  <official_title>Emotional and Change-related Attention in Autism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several studies seem to indicate that emotional attention and change-related attention are&#xD;
      impaired in ASD. The goal of this study is to identify the relationships between those two&#xD;
      types of automatic attention in visual and auditory modalities in subjects with ASD compared&#xD;
      to healthy controls and also, over the course of development (children, adults). In order to&#xD;
      achieve this goal, the investigators will use complementary techniques (EEG and MRI-based&#xD;
      techniques (fMRI, DTI)).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autism Spectrum Disorders (ASD) are characterized by major handicap in social interaction and&#xD;
      in daily life adaptation. The orienting response towards potentially relevant events involves&#xD;
      automatic attentional mechanisms that would be elicited mainly by two classes of biologically&#xD;
      important stimulations: novel stimuli and emotional stimuli. The neural basis of emotional&#xD;
      and change-related attention in ASD will be explored by investigating brain reactivity in&#xD;
      both visual and auditory modalities, during tasks mixing emotional and non emotional stimuli.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 27, 2014</start_date>
  <completion_date type="Actual">May 27, 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neural responses to neutral and emotional stimuli</measure>
    <time_frame>1 day</time_frame>
    <description>ERP (Event-related potential), fMRI and DTI</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Autism Spectrum Disorders</condition>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Autism Spectrum Disorders</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI-based techniques</intervention_name>
    <description>fMRI, DTI</description>
    <arm_group_label>Autism Spectrum Disorders</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
    <other_name>Functional magnetic resonance imaging</other_name>
    <other_name>Diffusion Tensor Imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EEG</intervention_name>
    <description>ERP</description>
    <arm_group_label>Autism Spectrum Disorders</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
    <other_name>Electroencephaolgraphy</other_name>
    <other_name>Event-related potential (ERP)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children/ adults with ASD and healthy children/ adults&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No past history of central nervous system disorders&#xD;
&#xD;
          -  Written consent&#xD;
&#xD;
          -  Affiliated to the National Health Insurance&#xD;
&#xD;
          -  Do not participate to another biomedical research&#xD;
&#xD;
          -  For ASD group: Children with autism spectrum disorder (DSM-V criteria) and adults with&#xD;
             high-functioning autism&#xD;
&#xD;
          -  For healthy subjects: No past history of difficulties in early childhood for&#xD;
             acquisition of walk, language or reading and no psychiatric disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Abnormal corrected vision&#xD;
&#xD;
          -  Abnormal audition&#xD;
&#xD;
          -  Not stabilized psychoactive treatment or treatment that can modify electrogenesis&#xD;
&#xD;
          -  Infectious or metabolic diseases&#xD;
&#xD;
          -  Epilepsies&#xD;
&#xD;
          -  Impossibility to participate to the whole study&#xD;
&#xD;
          -  For subjects participating to the MRI recordings: MRI counter-indications (pace-makers&#xD;
             ...), claustrophobia or a positive pregnancy test&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédérique BONNET-BRILHAULT, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 3, 2014</study_first_submitted>
  <study_first_submitted_qc>June 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2014</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autism Spectrum Disorders</keyword>
  <keyword>Emotion</keyword>
  <keyword>Attention</keyword>
  <keyword>Event-related potential</keyword>
  <keyword>Functional neuroimaging</keyword>
  <keyword>Diffusion Tensor Imaging</keyword>
  <keyword>Development</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

